Alphabet and Merck Group could exit the immunological and inflammatory disease therapy developer in an offering with an $86.3m placeholder target.

Carlyle Group has agreed to pay $435m for the biologics research technology provider, which has raised $86m from investors including Novo.

UK’s Ian McClure has been promoted to associate vice-president for research, innovation and economic impact, having previously been executive director of the tech transfer office.

The Intel Capital-backed community engagement platform developer took its total funding to $67m with the close of its series B round.

Based on research at MIT, LiquiGlide has brought its overall funding to $50m following a $13.5m round.

University of Pennsylvania is working on a treatment for solid tumours and its only known investor is HLB Pharmaceutical.

Limited partners include drugs maker Pfizer, and healthcare-focused JSR Group and Lonza.

Vehicle charging technology developer Virta has closed an Eneos-backed round at $36m while Hubert Burda-backed wealth manager StashAway pushed its total funding past $60m.

Tencent and CapitalG-backed automation technology provider UiPath has issued approximately $200m of extra shares to close its initial public offering.

The GV, Relx and Editions Lefebvre Sarrut-backed digital legal services provider has secured growth financing in a round led by Vista Credit Partners.